Disseminated intravascular coagulation after infusion of FEIBA (factor VIII inhibitor bypassing activity) in a patient with acquired haemophilia.
作者信息
Rodeghiero F, Castronovo S, Dini E
出版信息
Thromb Haemost. 1982 Dec 27;48(3):339-40.
PMID:6984544
Abstract
摘要
相似文献
1
Disseminated intravascular coagulation after infusion of FEIBA (factor VIII inhibitor bypassing activity) in a patient with acquired haemophilia.
Thromb Haemost. 1982 Dec 27;48(3):339-40.
2
Laboratory evidence of DIC under FEIBA treatment of a hemophilic patient with intracranial bleeding and high titre factor VIII inhibitor.
Thromb Res. 1981;22(1-2):177-84. doi: 10.1016/0049-3848(81)90319-4.
3
4
Thrombogenicity associated with factor IX complex concentrates.与凝血因子IX复合物浓缩物相关的血栓形成性。
Semin Hematol. 1991 Jul;28(3 Suppl 6):3-5.
5
6
[Clinical effects of FEIBA on hemophilia patients with inhibitors to factor VIII or IX].[活化凝血酶原复合物（FEIBA）对伴有Ⅷ或Ⅸ因子抑制物的血友病患者的临床疗效]
Nihon Ketsueki Gakkai Zasshi. 1982 Sep;45(5):987-92.
7
Effects of low-dose 'factor VIII inhibitor bypassing activity (FEIBA)' in resistant haemophilia.
Acta Haematol. 1980;64(1):12-7. doi: 10.1159/000207204.
8
9
The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation.凝血因子VIII和IX抑制物的诊断与管理：英国血友病中心医生组织指南
Br J Haematol. 2006 Jun;133(6):591-605. doi: 10.1111/j.1365-2141.2006.06087.x.
10
[Clinical use of factor IX concentrates].[凝血因子IX浓缩物的临床应用]
Schweiz Med Wochenschr. 1975 Sep 13;105(37):1188-90.
引用本文的文献
1
Myocardial infarction after FEIBA therapy in a hemophilia-B patient with a factor IX inhibitor.一名患有因子IX抑制剂的B型血友病患者在接受FEIBA治疗后发生心肌梗死。
Ann Hematol. 1992 Jun;64(6):309-11. doi: 10.1007/BF01695478.
Zotero 插件